CBH - a takeover target, remains to be proven if suitors are...

CBH - a takeover target, remains to be proven if suitors are fair dinkum or not (last TO announcement of offer of 0.195 was conditional), but todays' opening looks robust (0.18, so far). I bought in late Friday @ 0.175. Watching with interest.

CXS - a biotech in a wrestling match with the FDA. Will the FDA give approval for trial results submitted or won't they? Resolution expected this month, so could be very soon. Do not hold.

Best wishes for a good week, fellow travellers.

P.